Product Information
AZOR 5-40 MG TABLET is a brand product labeled by Cosette Pharmaceuticals, Inc., priced at $19.6346 per EA under NDC 00713087230. Its NADAC has been published 55 times since Sep 17, 2025.
FDA first approved this application on Sep 26, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5; 40 mg/1; mg/1
Manufacturer
Cosette Pharmaceuticals, Inc.NDC
00713087230
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
7/1/2026
Active Ingredients
AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMILApproval Type
New Drug (NDA)
FDA Application
NDA022100FDA Approved
9/26/2007
TE Code
AB
On Market Since
9/1/2022
Pharmacological Classes
Price Statistics
The NADAC for AZOR 5-40 MG TABLET has been published 55 times since Sep 17, 2025, and over the history we have for it it has risen 20.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $19.6346 per EA |
|---|---|
| All-time high | $19.6346 (Sep 30, 2026) |
| All-time low | $16.2565 (Sep 17, 2025) |
| 52-week high | $19.6346 |
| 52-week low | $17.8659 |
| Median price | $17.8659 |
| Average price | $18.2547 |
| Largest weekly change | +9.9% (Jul 8, 2026) |
| Weeks tracked | 55 |
| Tracking since | Sep 17, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the amlodipine besylate and olmesartan medoxomil market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cosette Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
amlodipine besylate and olmesartan medoxomil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin 2 Receptor Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AZOR 5-40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for AZOR 5-40 MG TABLET, manufactured by Cosette Pharmaceuticals, Inc., is $19.6346 per EA (NDC 00713087230), effective Sep 30, 2026.
How has the price of AZOR 5-40 MG TABLET changed over time?
Over the history we have for it, the NADAC for AZOR 5-40 MG TABLET has risen 20.8%. It has been tracked across 55 weekly CMS publications since Sep 17, 2025.
What are the highest and lowest recorded NADAC prices for AZOR 5-40 MG TABLET?
Since Sep 17, 2025, the NADAC for AZOR 5-40 MG TABLET has ranged from a low of $16.2565 (Sep 17, 2025) to a high of $19.6346 (Sep 30, 2026), with a median of $17.8659 per EA.
Are there cheaper alternatives to AZOR 5-40 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of AZOR 5-40 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures AZOR 5-40 MG TABLET?
AZOR 5-40 MG TABLET (NDC 00713087230) is labeled by Cosette Pharmaceuticals, Inc., and CMS classifies it as a brand product.